Expression of CD133 correlates with tumor stage, lymph node metastasis and recurrence in oral Squamous cell carcinoma

Journal of Cancer Science and Therapy

Volumn 6, Issue 3, 2014, Pages 94-98

  Reggiani Bonetti, L ^a   Migaldi, M ^a   Boninsegna, A ^b   Fanali, C ^b   Farina, M ^b   Chiarini, L ^a   Anesi, A ^a   Cittadini, A ^b   Leocata, P ^c   Maccio, L ^a   Sgambato, A ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CD133; Oral cancer; Oral squamous carcinoma; Prognostic marker; Tumorigenesis

Indexed keywords

CD133 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

EID: 84898912555     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000255     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Mydlarz WK, Hennessey PT, Califano JA (2010) Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn 4: 53-65.
3. Massano J, Regateiro FS, Januário G, Ferreira A (2006) Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 102: 67-76.
4. Vermeulen L, de Sousa E, Melo F, Richel DJ, Medema JP (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13: e83-89.
5. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
6. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, et al. (2009) Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol 45: 633-639.
7. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, et al. (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289: 151-160.
8. Felthaus O, Ettl T, Gosau M, Driemel O, Brockhoff G, et al. (2011) Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. BiochemBiophys Res Commun 407: 28-33.
9. Zhang Z, Filho MS, Nör JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48: 1-9.
10. Pang LY, Bergkvist GT, Cervantes-Arias A, Yool DA, Muirhead R, et al. (2012) Identifcation of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for geftinib induced epithelial to mesenchymal transition. Vet J 193: 46-52.
11. World Health Organization (2005) International Classifcation of Diseases. Edited by Geneva, Switzerland, IARC press.
12. AJCC (American Joint Committee on Cancer) (2002) Cancer Staging Manual. Edited by Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D, Morrow M. New York, USA, Springer - Verlag.
13. Arena V, Caredda E, Cufno V, Stigliano E, Scaldaferri F, et al. (2011) Differential CD133 expression pattern during mouse colon tumorigenesis. Anticancer Res 31: 4273-4275.
14. ReggianiBonetti L, Migaldi M, Caredda E, Ponz de Leon M, Di Gregorio C, et al. (2012) Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Scand J Gastroenterol 47: 1211-1217.
15. Coco C, Zannoni GF, Caredda E, Sioletic S, Boninsegna A, et al. (2012) Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. J Exp Clin Cancer Res 31: 71.
16. Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, et al. (2011) CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One 6: e28053.
17. Ravindran G, Devaraj H (2012) Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head Neck 34: 1129-1135.
18. Sinha N, Mukhopadhyay S, Das DN, Panda PK, Bhutia SK (2013) Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol 49: 854-862.
19. Sun L, Feng J, Ma L, Liu W, Zhou Z (2013) CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Ann DiagnPathol 17: 486-489.
20. Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, et al. (2013) Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. Int J Cancer 132: 868-874.
21. Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, et al. (2013) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 229: 355-378.
22. Schulenburg A, Ulrich-Pur H, Thurnher D, Erovic B, Florian S, et al. (2006) Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer 107: 2512-2520.
23. Damek-Poprawa M, Volgina A, Korostoff J, Sollecito TP, Brose MS, et al. (2011) Targeted inhibition of CD133+ cells in oral cancer cell lines. J Dent Res 90: 638-645.
24. Sgambato A, Errico F, Caredda E, Puglisi MA, Cittadini A (2011) Divergent expression of CD133 in different studies: the need for a consensus panel? Int J Cancer 128: 2247-2249.